ETON Insider Trading
Insider Ownership Percentage: 14.89%
Insider Buying (Last 12 Months): $462,673.60
Insider Selling (Last 12 Months): $0.00
Eton Pharmaceuticals Insider Trading History Chart
This chart shows the insider buying and selling history at Eton Pharmaceuticals by year and by quarter.
Skip ChartChart Data in Insider Trading History Table
Eton Pharmaceuticals Share Price & Price History
Current Price: $13.02
Price Change: ▼ Price Decrease of -0.49 (-3.63%)
As of 03/28/2025 05:00 PM ET
Eton Pharmaceuticals Insider Trading History
Eton Pharmaceuticals Institutional Trading History
Data available starting January 2016
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing, acquiring, and commercializing pharmaceutical products for rare diseases. The company offers ALKINDI SPRINKLE, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of tyrosinemia type 1. It also provides Zeneo hydrocortisone autoinjector for the treatment of adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.
Read More on Eton Pharmaceuticals
Today's Range
Now: $13.02
52 Week Range
Now: $13.02
Volume
173,499 shs
Average Volume
161,360 shs
Market Capitalization
$349.17 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.37
Who are the company insiders with the largest holdings of Eton Pharmaceuticals?
Who are the major institutional investors of Eton Pharmaceuticals?
Which major investors are selling Eton Pharmaceuticals stock?
Within the previous quarter, ETON stock was sold by these institutional investors:
- Acuitas Investments LLC
- Paradigm Capital Management Inc. NY
- Westside Investment Management Inc.
- EAM Investors LLC
- Bridgeway Capital Management LLC
- Wasatch Advisors LP
- Geode Capital Management LLC
- Essex Investment Management Co. LLC
Which major investors are buying Eton Pharmaceuticals stock?
In the previous quarter, ETON stock was acquired by institutional investors including:
- Mink Brook Asset Management LLC
- Cannell Capital LLC
- Connor Clark & Lunn Investment Management Ltd.
- Millennium Management LLC
- Nantahala Capital Management LLC
- Two Sigma Investments LP
- Renaissance Technologies LLC
- Schonfeld Strategic Advisors LLC